Genomic Drug Discovery Startup Warp Drive Launches with $125M from Sanofi, Other Backers | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Warp Drive Bio, a new firm that plans to apply a "genomic search engine" to identify new drugs in microbes, kicked off today with $125 million in initial financing from Sanofi, Third Rock Ventures, and Greylock Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.